These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 5837205)

  • 21. A study on pulmonary disease associated with mycobacteria other than Mycobacterium tuberculosis: identification and characterization of the mycobacteria. 18. A report of the Veterans Administration-Armed Forces Cooperative Study.
    Hobby GL; Redmond WB; Runyon EH; Schaefer WB; Wayne LG; Wichelhausen RH
    Am Rev Respir Dis; 1967 Jun; 95(6):954-71. PubMed ID: 4961231
    [No Abstract]   [Full Text] [Related]  

  • 22. Recent developments in the diagnosis and management of mycobacterial infections.
    Sommers HM
    Clin Lab Med; 1982 Jun; 2(2):305-19. PubMed ID: 6811187
    [No Abstract]   [Full Text] [Related]  

  • 23. Secondary anti-tuberculosis drugs. II: resistant typical mycobacterium tuberculosis, unclassified mycobacteria.
    J Kans Med Soc; 1968 Nov; 69(11):534-6 concl. PubMed ID: 4972834
    [No Abstract]   [Full Text] [Related]  

  • 24. [Lung disease due to mycobacteria other than Mycobacterium tuberculosis in Japanese national chest hospitals. Geographic distribution of the prevalence of the mycobacteria and the disease (author'stransl)].
    Tsukamura M; Shimoide H; Kita N; Kondo H; Ito T
    Kekkaku; 1976 Apr; 51(4):99-107. PubMed ID: 933418
    [No Abstract]   [Full Text] [Related]  

  • 25. An analysis of "atypical" mycobacteria as reported by the South Carolina State Board of Health Laboratory.
    Townsend EW; Geiger FL; Gregg DB; Fickling AM
    J S C Med Assoc; 1965 Sep; 61(9):267-73. PubMed ID: 5212728
    [No Abstract]   [Full Text] [Related]  

  • 26. THE PATHOGENIC "ATYPICAL" MYCOBACTERIA.
    YOUMANS GP
    Annu Rev Microbiol; 1963; 17():473-94. PubMed ID: 14145309
    [No Abstract]   [Full Text] [Related]  

  • 27. [Drug sensitivity of atypical Mycobacteria isolated from patients to antitubercular agents of the first and second order].
    Makarevich NM; Rudoĭ NM
    Antibiotiki; 1971 Feb; 16(2):149-52. PubMed ID: 4326726
    [No Abstract]   [Full Text] [Related]  

  • 28. Atypical mycobacteria in pulmonary tuberculosis.
    Saini S; Arora DR; Chugh TD
    J Indian Med Assoc; 1977 Nov; 69(10):222-4. PubMed ID: 615912
    [No Abstract]   [Full Text] [Related]  

  • 29. Studies on mycobacteria isolated in Pondicherry.
    Madhavan HN; Sharma KB
    Indian J Chest Dis; 1969 Oct; 11(4):196-9. PubMed ID: 5398325
    [No Abstract]   [Full Text] [Related]  

  • 30. [Disposition to lung diseases caused by atypical mycobacteria; treatment results and late results].
    Krebs A
    Z Tuberk Erkr Thoraxorg; 1967; 127(1):133-40. PubMed ID: 5632190
    [No Abstract]   [Full Text] [Related]  

  • 31. CHANGING CONCEPTS IN TUBERCULOSIS. THE ANONYMOUS MYCOBACTERIA.
    ALBERTSON JN
    Arch Intern Med; 1964 May; 113():676-8. PubMed ID: 14120592
    [No Abstract]   [Full Text] [Related]  

  • 32. Genitourinary infection due to Mycobacterium kansasii.
    Hepper NG; Karlson AG; Leary FJ; Soule EH
    Mayo Clin Proc; 1971 Jun; 46(6):387-90. PubMed ID: 5088980
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparative evaluation of the in vitro antimycobacterial activities of six aminoglycoside antibiotics using an agar dilution method.
    Udou T
    J Chemother; 2006 Dec; 18(6):610-6. PubMed ID: 17267338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atypical mycobacteria in a tuberculosis hospital.
    Gale GL
    Can Med Assoc J; 1976 Apr; 114(7):612-4. PubMed ID: 1260602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent experience in the epidemiology of disease caused by atypical mycobacteria.
    Gruft H; Falkinham JO; Parker BC
    Rev Infect Dis; 1981; 3(5):990-6. PubMed ID: 7339831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection and identification of non-tuberculous mycobacterial infections in 6,472 tuberculosis suspected patients.
    Bahrmand AR; Madani H; Samar G; Khalilzadeh L; Bakayev VV; Yaghli M; babaei MH
    Scand J Infect Dis; 1996; 28(3):275-8. PubMed ID: 8863361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro drug susceptibility of 2275 clinical non-tuberculous Mycobacterium isolates of 49 species in The Netherlands.
    van Ingen J; van der Laan T; Dekhuijzen R; Boeree M; van Soolingen D
    Int J Antimicrob Agents; 2010 Feb; 35(2):169-73. PubMed ID: 20006470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Characteristics of Mycobacteria from patients with genital tuberculosis].
    Blagodarnyĭ IaA; Alimbekova OA; Blonskaia LI
    Probl Tuberk; 1990; (1):37-41. PubMed ID: 2110667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A study on the frequency of 'atypical' Mycobacteria and of 'atypical' mycobacterioses in Japanese National Chest Hospitals. (Report of the year 1971-1972)].
    Tsukamura M; Shimoide H; Kita N; Segawa J; Ito T
    Kekkaku; 1973 May; 48(5):203-11. PubMed ID: 4732659
    [No Abstract]   [Full Text] [Related]  

  • 40. Nontuberculous mycobacteria: susceptibility pattern and prevalence rate in Shanghai from 2005 to 2008.
    Wang HX; Yue J; Han M; Yang JH; Gao RL; Jing LJ; Yang SS; Zhao YL
    Chin Med J (Engl); 2010 Jan; 123(2):184-7. PubMed ID: 20137367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.